| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Dyne Therapeutics, Inc. | Director | Common Stock | 1.96M | $26.4M | $13.50 | 27 Jan 2025 | Indirect |
| Generation Bio Co. | Director | Stock Option (right to buy) | 30K | $275K | $4.59 | 04 Jun 2025 | Direct |
| Dyne Therapeutics, Inc. | Director | Stock option (right to buy) | 35K | 30 May 2025 | Direct | ||
| Gemini Therapeutics, Inc. /DE | Director, 10%+ Owner | Stock Option (Right to Buy) | 17.2K | 04 Oct 2021 | Direct | ||
| Replimune Group, Inc. | Director | Stock Option (right to buy) | 16.5K | 01 Apr 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GBIO | Generation Bio Co. | 04 Jun 2025 | 1 | $0 | 4 | Director | 06 Jun 2025, 16:05 |
| DYN | Dyne Therapeutics, Inc. | 30 May 2025 | 1 | $0 | 4 | Director | 03 Jun 2025, 21:39 |
| DYN | Dyne Therapeutics, Inc. | 27 Jan 2025 | 1 | $15M | 4 | Director | 29 Jan 2025, 16:15 |
| DYN | Dyne Therapeutics, Inc. | 14 Nov 2024 | 4 | -$25.9K | 4 | Director | 18 Nov 2024, 17:31 |
| GBIO | Generation Bio Co. | 06 Jun 2024 | 1 | $0 | 4 | Director | 10 Jun 2024, 16:05 |
| DYN | Dyne Therapeutics, Inc. | 22 May 2024 | 1 | $0 | 4 | Director | 24 May 2024, 17:10 |
| DYN | Dyne Therapeutics, Inc. | 01 Mar 2024 | 2 | -$1.4M | 4 | Director | 05 Mar 2024, 17:08 |
| DYN | Dyne Therapeutics, Inc. | 26 Feb 2024 | 18 | -$19.6M | 4 | Director | 28 Feb 2024, 19:15 |
| DYN | Dyne Therapeutics, Inc. | 21 Feb 2024 | 6 | -$11.3M | 4 | Director | 23 Feb 2024, 18:59 |
| DYN | Dyne Therapeutics, Inc. | 15 Feb 2024 | 5 | -$11.9M | 4 | Director | 20 Feb 2024, 18:36 |
| GBIO | Generation Bio Co. | 08 Jun 2023 | 1 | $0 | 4 | Director | 12 Jun 2023, 16:15 |
| DYN | Dyne Therapeutics, Inc. | 24 May 2023 | 1 | $0 | 4 | Director | 25 May 2023, 18:38 |
| DYN | Dyne Therapeutics, Inc. | 12 Dec 2022 | 1 | $10M | 4 | Director | 14 Dec 2022, 15:56 |
| GBIO | Generation Bio Co. | 09 Jun 2022 | 1 | $0 | 4 | Director | 13 Jun 2022, 16:05 |
| DYN | Dyne Therapeutics, Inc. | 03 Jun 2022 | 1 | $0 | 4 | Director | 06 Jun 2022, 18:42 |
| REPL | Replimune Group, Inc. | 01 Apr 2022 | 1 | $0 | 4 | Director | 05 Apr 2022, 16:13 |
| IRON | Gemini Therapeutics, Inc. /DE | 04 Oct 2021 | 1 | $0 | 4 | Director, 10%+ Owner | 06 Oct 2021, 16:15 |
| GBIO | Generation Bio Co. | 27 Sep 2021 | 6 | -$2.06M | 4 | Director | 29 Sep 2021, 19:16 |
| GBIO | Generation Bio Co. | 22 Sep 2021 | 7 | -$3.51M | 4 | Director | 24 Sep 2021, 21:02 |
| GBIO | Generation Bio Co. | 24 Jun 2021 | 4 | -$802K | 4 | Director | 28 Jun 2021, 16:57 |
| GBIO | Generation Bio Co. | 21 Jun 2021 | 12 | -$4.64M | 4 | Director | 23 Jun 2021, 20:27 |
| GBIO | Generation Bio Co. | 09 Jun 2021 | 1 | $0 | 4 | Director | 11 Jun 2021, 16:14 |
| DYN | Dyne Therapeutics, Inc. | 26 May 2021 | 1 | $0 | 4 | Director | 27 May 2021, 20:38 |